Federal contract award
692M1524F00022
SOFTWARE ASSET MANAGEMENT SUPPORT (SLI 49406) - ADD FUNDING FOR BASE YEAR IN THE AMOUNT OF $565,805.06 FOR CLIN 002 - ADD FUNDING $28,870.50 FOR CLIN 004 THE PERIOD OF PERFORMANCE IS 12/12/2023 - 03/31/2024 THIS IS START UP FUNDING. SLI 49
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Transportation |
| Office | 692M15 ACQUISITION & GRANTS, AAQ600 |
| NAICS | 541330 — Engineering Services |
| PSC | R499 — Other Professional Services |
| Parent award / vehicle | 693KA822D00020 |
| Set-aside | Not reported |
| Pricing type | TIME AND MATERIALS |
| Obligations | $6.9M |
| Current contract value | $6.9M |
| Potential contract value / ceiling | $7.0M |
| Start date | Dec 6, 2023 |
| Current end date | Dec 6, 2026 |
| Potential end date | Dec 6, 2026 |
| Latest award activity | Jul 21, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 18 of 18 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 21, 2026 | P00017 | $160.0K | INCREMENTAL FUNDING |
| Apr 20, 2026 | P00016 | $799.2K | INCREMENTAL FUNDING AND RE-ALLIGNMENT |
| Feb 12, 2026 | P00015 | $0 | PWS MOD FOR LCAT |
| Dec 5, 2025 | P00014 | $884.4K | INCREMENTAL FUNDING - OPTION PERIOD 1 |
| Sep 12, 2025 | P00013 | $0 | INCREMENTAL FUNDING - OPTION PERIOD 1 |
| Jul 1, 2025 | P00012 | $946.8K | INCREMENTAL FUNDING - OPTION PERIOD 1 |
| May 14, 2025 | P00011 | $0 | SOFTWARE ASSET MANAGEMENT SUPPORT (SLI 49406) - ADD FUNDING FOR BASE YEAR IN THE AMOUNT OF $565,805.06 FOR CLIN 002 - ADD FUNDING $28,870.50 FOR CLIN 004 THE PERIOD OF PERFORMANCE IS 12/12/2023 - 03/31/2024 THIS IS START UP FUNDING. SLI 49 |
| Apr 7, 2025 | P00010 | $0 | SOFTWARE ASSET MANAGEMENT SUPPORT (SLI 49406) - ADD FUNDING FOR BASE YEAR IN THE AMOUNT OF $565,805.06 FOR CLIN 002 - ADD FUNDING $28,870.50 FOR CLIN 004 THE PERIOD OF PERFORMANCE IS 12/12/2023 - 03/31/2024 THIS IS START UP FUNDING. SLI 49 |
| Feb 3, 2025 | P00009 | $932.9K | SOFTWARE ASSET MANAGEMENT SUPPORT (SLI 49406) - ADD FUNDING FOR BASE YEAR IN THE AMOUNT OF $565,805.06 FOR CLIN 002 - ADD FUNDING $28,870.50 FOR CLIN 004 THE PERIOD OF PERFORMANCE IS 12/12/2023 - 03/31/2024 THIS IS START UP FUNDING. SLI 49 |
| Dec 16, 2024 | P00008 | $0 | SOFTWARE ASSET MANAGEMENT SUPPORT (SLI 49406) - ADD FUNDING FOR BASE YEAR IN THE AMOUNT OF $565,805.06 FOR CLIN 002 - ADD FUNDING $28,870.50 FOR CLIN 004 THE PERIOD OF PERFORMANCE IS 12/12/2023 - 03/31/2024 THIS IS START UP FUNDING. SLI 49 |
| Dec 4, 2024 | P00007 | $672.4K | SOFTWARE ASSET MANAGEMENT SUPPORT (SLI 49406) - ADD FUNDING FOR BASE YEAR IN THE AMOUNT OF $565,805.06 FOR CLIN 002 - ADD FUNDING $28,870.50 FOR CLIN 004 THE PERIOD OF PERFORMANCE IS 12/12/2023 - 03/31/2024 THIS IS START UP FUNDING. SLI 49 |
| Nov 13, 2024 | P00006 | $100.1K | SOFTWARE ASSET MANAGEMENT SUPPORT (SLI 49406) - ADD FUNDING FOR BASE YEAR IN THE AMOUNT OF $565,805.06 FOR CLIN 002 - ADD FUNDING $28,870.50 FOR CLIN 004 THE PERIOD OF PERFORMANCE IS 12/12/2023 - 03/31/2024 THIS IS START UP FUNDING. SLI 49 |
| Sep 11, 2024 | P00005 | $30.0K | SOFTWARE ASSET MANAGEMENT SUPPORT (SLI 49406) - ADD FUNDING FOR BASE YEAR IN THE AMOUNT OF $565,805.06 FOR CLIN 002 - ADD FUNDING $28,870.50 FOR CLIN 004 THE PERIOD OF PERFORMANCE IS 12/12/2023 - 03/31/2024 THIS IS START UP FUNDING. SLI 49 |
| Jul 19, 2024 | P00004 | $55.9K | SOFTWARE ASSET MANAGEMENT SUPPORT (SLI 49406) - ADD FUNDING FOR BASE YEAR IN THE AMOUNT OF $565,805.06 FOR CLIN 002 - ADD FUNDING $28,870.50 FOR CLIN 004 THE PERIOD OF PERFORMANCE IS 12/12/2023 - 03/31/2024 THIS IS START UP FUNDING. SLI 49 |
| May 21, 2024 | P00003 | $1.0M | SOFTWARE ASSET MANAGEMENT SUPPORT (SLI 49406) - ADD FUNDING FOR BASE YEAR IN THE AMOUNT OF $565,805.06 FOR CLIN 002 - ADD FUNDING $28,870.50 FOR CLIN 004 THE PERIOD OF PERFORMANCE IS 12/12/2023 - 03/31/2024 THIS IS START UP FUNDING. SLI 49 |
| Apr 1, 2024 | P00002 | $334.9K | SOFTWARE ASSET MANAGEMENT SUPPORT (SLI 49406) - ADD FUNDING FOR BASE YEAR IN THE AMOUNT OF $565,805.06 FOR CLIN 002 - ADD FUNDING $28,870.50 FOR CLIN 004 THE PERIOD OF PERFORMANCE IS 12/12/2023 - 03/31/2024 THIS IS START UP FUNDING. SLI 49 |
| Mar 27, 2024 | P00001 | $0 | SOFTWARE ASSET MANAGEMENT SUPPORT (SLI 49406) - ADD FUNDING FOR BASE YEAR IN THE AMOUNT OF $565,805.06 FOR CLIN 002 - ADD FUNDING $28,870.50 FOR CLIN 004 THE PERIOD OF PERFORMANCE IS 12/12/2023 - 03/31/2024 THIS IS START UP FUNDING. SLI 49 |
| Dec 6, 2023 | 0 | $930.7K | SOFTWARE ASSET MANAGEMENT SUPPORT (SLI 49406) - ADD FUNDING FOR BASE YEAR IN THE AMOUNT OF $565,805.06 FOR CLIN 002 - ADD FUNDING $28,870.50 FOR CLIN 004 THE PERIOD OF PERFORMANCE IS 12/12/2023 - 03/31/2024 THIS IS START UP FUNDING. SLI 49 |
Estimated positioning window
Oct 25, 2026 – Jan 23, 2027
75/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 75/100. Available recorded signals: 70 points.
- Contract end 2026-12-06 (42 days from calculation)
- +35 points
- 20 historical awards in this buyer and category group
- +15 points
- 18 recorded award transactions
- +10 points
- Latest award action: 2026-07-21
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.